Drug-Receptor Interactions Flashcards

1
Q

5 major types of cell receptors

A
Intracellular
Ligand-gated transmembrane proteins
Cytokine receptor mechanism
Ligand-gated ion channels
G-protein family of transmembrane receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cellular membrane components of a ligand-regulated transmembrane enzyme

A

Cytoplasmic hormone binding domain (TK, SK, or guanalyl cyclase), EC hormone binding domain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What prolongs the activation of a ligand-regulated transmembrane enzyme?

A

Autophosphorylation of tyrosine residues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cytokine receptor mechanisms

A

Closely resembles tyrosine kinase but utilizes a separate protein tyrosine kinase that binds non-covalently to the membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ligand-gated channel receptors - membrane components

A

Pentamer: 2 alpha subunits, then beta, delta, and gamma. Drug binds to an alpha subunit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Common example of a ligand-gated channel receptor

A

Nicotinic cholinergic receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Membrane structure in G-protein coupled receptor

A

Polypeptide that spans the membrane 7 times, with amino group on the extracellular side and carboxy group in the cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Steps involved in the adenylyl cyclase pathway

A
  1. Agonist binds and ternary complex forms
  2. Ternary complex binds GTP rather than GDP
  3. GTP and alpha subunit dissociate from beta-gamma
  4. Alpha subunit stimulates breakdown of ATP into cAMP and activates PKA. cAMP and PKA have downstream targets.
  5. Alpha subunit remains active until the GTPase converts GTP back to GDP.
  6. Non-active alpha subunit with bound GDP reforms the ternary complex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the steps involved in receptor signaling via the phospholipase C pathway

A
  1. Agonist binds and ternary complex forms
  2. Ternary complex binds GTP rather than GDP
  3. GTP and alpha subunit dissociate from beta-gamma
  4. Alpha subunit stimulates PLC, which will facilitate breakdown of PIP2 into IP3 and DAG. IP3 stimulates release of intracellular calcium from the ER, activating calmodulin. DAG activates PKC.
  5. Alpha subunit remains active until the GTPase converts GTP back to GDP.
  6. Non-active alpha subunit with bound GDP reforms the ternary complex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Three ways by which drugs can produce beneficial vs toxic

A

Actions at the same receptor, producing direct extension of the drug
Actions at the same receptors at different tissues
Actions by different types of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Idiosyncratic drug response

A

Unusual response that is not frequently observed in the majority of patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tachyphylaxis

A

Rapid development of diminished responsiveness after administration of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacodynamic tolerance - different methods

A

Binding of beta-arrestin
Loss of membrane-bound receptors
Uncoupling from post-receptor moieties from functional modification of G-proteins and/or subsequent second messenger enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of homologous desensitization

A

GRK2 and GRK3 functionally uncouple receptors and trigger sequestration from the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanism of heterologous desensitization

A

Several protein kinases promote phosphorylation of receptors, PKA, and PKC. This functionally uncouples receptors and impairs interactions with G-proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Supersensitivity

A

Compensatory mechanism from the loss of hormonal activity on receptors leading to increase in the number of receptors and/or enhanced receptor-effector coupling.